KYNB

FIBROGEN, INC.

KYNB · CIK 921299 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$30M
20172024
Net Income−$48M
20172024
Operating CF−$138M
20172024
Free Cash Flow−$138M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.1B$0.1B$0.2B$0.2B$0.3B$0.2B$0.1B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B————
Gross Profit————————
R&D Expense$0.1B$0.3B$0.3B$0.4B$0.3B$0.2B$0.2B$0.2B
SG&A Expense$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B——
Operating Income$-0.2B$-0.3B$-0.3B$-0.3B$-0.2B$-0.1B$-0.1B$-0.1B
Net Income$-0.0B$-0.3B$-0.3B$-0.3B$-0.2B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-0.48$-2.92$-3.14—————
EPS (Diluted)$-0.48$-2.92$-3.14—————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.2B$0.4B$0.6B$0.8B$0.8B$0.9B$0.9B$0.9B
Current Assets$0.2B$0.3B$0.5B$0.5B$0.8B$0.7B$0.7B$0.7B
Cash & Equivalents$0.1B$0.1B$0.2B$0.2B$0.7B$0.1B$0.1B$0.7B
Total Liabilities$0.4B$0.6B$0.6B$0.5B$0.4B$0.3B$0.4B$0.3B
Current Liabilities$0.1B$0.2B$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B
Stockholders' Equity$-0.2B$-0.2B$-0.0B$0.2B$0.4B$0.5B$0.5B$0.6B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.1B$-0.3B$-0.1B$-0.1B$0.1B$-0.1B$-0.1B—
Investing Cash Flow$0.1B$0.2B$0.1B$-0.4B$0.5B$0.1B$-0.5B—
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.1B$0.0B$-0.0B$0.0B$-0.0B$0.0B—
← Companies